MIDA HEALTH Trademark

Trademark Overview


On Monday, December 2, 2024, a trademark application was filed for MIDA HEALTH with the United States Patent and Trademark Office. The USPTO has given the MIDA HEALTH trademark a serial number of 98880892. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, March 13, 2025. This trademark is owned by M&D Supplements LLC. The MIDA HEALTH trademark is filed in the Pharmaceutical Products category with the following description:

Dietary supplements; Nutritional supplements
mida health

General Information


Serial Number98880892
Word MarkMIDA HEALTH
Filing DateMonday, December 2, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, March 13, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDietary supplements; Nutritional supplements

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 2, 2024
Primary Code005
First Use Anywhere DateThursday, July 6, 2023
First Use In Commerce DateThursday, July 6, 2023

Trademark Owner History


Party NameM&D Supplements LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSt. Petersburg, FL 33702

Trademark Events


Event DateEvent Description
Monday, December 2, 2024NEW APPLICATION ENTERED
Monday, December 2, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 13, 2025ASSIGNED TO EXAMINER
Thursday, March 13, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 13, 2025NON-FINAL ACTION WRITTEN
Thursday, March 13, 2025NON-FINAL ACTION E-MAILED